Stock ScreenerStock IdeasBest Value Stocks to Buy Now
Best Value Stocks to Buy Right Now (2025)
A list of the best value stocks to buy right now, based on the proven Zen Ratings quant model. "A" Rated stocks averaged +32.52% return. Learn More

Zen Rating: A + 1 more
Value Rating: A + 1 more
Ticker
Company
Zen Rating
Sentiment
Market Cap
Shares
Institutional %
Insider %
Net Insider (L12M)
Net Insider (L3M)
CRTO
CRITEO SA
AB$1.28B53,141,86989.50%10.50%Net SellingNet Selling
HLF
HERBALIFE LTD
BB$801.53M101,846,73119.15%80.85%Net SellingNet Selling
MOMO
HELLO GROUP INC
BA$1.40B339,405,34721.17%0.00%
CCSI
CONSENSUS CLOUD SOLUTIONS INC
BB$423.06M19,540,93787.58%12.42%Net SellingNet Selling
JAKK
JAKKS PACIFIC INC
BC$230.62M11,146,23021.89%78.11%Net SellingNet Selling
PBYI
PUMA BIOTECHNOLOGY INC
AC$166.29M49,638,09358.13%41.87%Net Selling
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
BC$1.89B57,424,31970.06%29.94%Net SellingNet Selling
GTEC
GREENLAND TECHNOLOGIES HOLDING CORP
BC$34.79M17,394,2262.26%38.25%Net BuyingNet Buying
USNA
USANA HEALTH SCIENCES INC
BB$550.31M18,623,07518.77%81.23%Net SellingNet Selling
ENS
ENERSYS
AC$3.39B39,196,21548.88%51.12%Net SellingNet Buying
MAPS
WM TECHNOLOGY INC
AC$157.46M154,373,30828.60%41.38%Net SellingNet Selling
BTMD
BIOTE CORP
AB$191.32M50,614,05728.71%71.29%Net BuyingNet Buying
LGPS
LOGPROSTYLE INC
BCN/A24,527,1100.00%0.00%
DLNG
DYNAGAS LNG PARTNERS LP
BC$133.36M36,737,63510.36%0.00%
CNC
CENTENE CORP
BC$27.48B497,603,00091.86%3.47%Net SellingNet Selling
ARDT
ARDENT HEALTH PARTNERS INC
AA$1.88B143,043,66146.07%53.93%Net SellingNet Selling
LFVN
LIFEVANTAGE CORP
AB$156.47M12,588,18319.65%80.35%Net SellingNet Selling
INSE
INSPIRED ENTERTAINMENT INC
BC$199.15M26,912,20137.13%62.87%Net Selling
SNCR
SYNCHRONOSS TECHNOLOGIES INC
BD$76.12M11,497,9768.47%91.53%Net SellingNet Selling
CALM
CAL-MAINE FOODS INC
BD$4.73B49,045,95559.92%40.08%Net SellingNet Selling
AUNA
AUNA SA
BC$467.12M73,970,2996.00%0.00%
CNXC
CONCENTRIX CORP
BC$3.53B63,883,47767.68%32.32%Net SellingNet Selling
REPX
RILEY EXPLORATION PERMIAN INC
BD$626.34M22,023,03614.35%85.65%Net SellingNet Selling
VEON
VEON LTD
AC$2.83B1,849,190,6670.92%0.00%
TDC
TERADATA CORP
BC$2.05B95,600,00093.86%6.14%Net SellingNet Selling
BHF
BRIGHTHOUSE FINANCIAL INC
BD$3.27B57,408,98680.95%1.39%Net SellingNet Selling
COMM
COMMSCOPE HOLDING COMPANY INC
AC$1.26B216,597,03887.18%8.27%Net SellingNet Selling
ADT
ADT INC
AB$6.78B836,510,47567.46%32.54%Net SellingNet Selling
BMY
BRISTOL MYERS SQUIBB CO
BC$101.25B2,035,080,81078.14%0.37%Net SellingNet Selling
EMBC
EMBECTA CORP
BA$558.71M58,442,50897.71%2.28%Net SellingNet Selling
SUPN
SUPERNUS PHARMACEUTICALS INC
BC$1.79B55,989,62346.12%53.88%Net Selling
COLL
COLLEGIUM PHARMACEUTICAL INC
BC$937.91M32,142,19256.76%43.24%Net SellingNet Selling
OSPN
ONESPAN INC
BB$592.19M38,230,46778.99%21.01%Net SellingNet Selling
KEP
KOREA ELECTRIC POWER CORP
AB$13.12B641,964,0772.90%0.00%
ULBI
ULTRALIFE CORP
AB$128.74M16,632,96524.66%75.34%Net BuyingNet Buying
RNG
RINGCENTRAL INC
BD$2.33B89,936,22489.06%10.94%Net SellingNet Selling
NATR
NATURES SUNSHINE PRODUCTS INC
AA$264.62M18,350,80123.12%76.88%Net Buying
ACI
ALBERTSONS COMPANIES INC
BC$12.22B575,749,85747.33%52.67%Net SellingNet Selling
YELP
YELP INC
AC$2.26B63,842,42880.63%19.37%Net SellingNet Selling
ASIX
ADVANSIX INC
AC$643.24M26,812,68789.01%5.69%Net SellingNet Selling
CRUS
CIRRUS LOGIC INC
BA$5.20B51,560,13595.35%3.10%Net SellingNet Selling
RCMT
RCM TECHNOLOGIES INC
AB$167.02M7,390,38534.25%65.75%Net SellingNet Selling
VNT
VONTIER CORP
BC$5.25B147,900,00096.99%0.99%Net SellingNet Buying
RCKY
ROCKY BRANDS INC
AB$160.71M7,461,16771.30%9.94%Net SellingNet Buying
GPI
GROUP 1 AUTOMOTIVE INC
BC$5.50B12,934,71987.44%12.56%Net SellingNet Selling
EXEL
EXELIXIS INC
AA$11.34B272,708,28091.77%5.25%Net SellingNet Selling
SGU
STAR GROUP LP
AC$401.66M34,565,97531.96%68.04%Net SellingNet Selling
DLX
DELUXE CORP
AC$659.91M44,739,84086.24%4.92%Net SellingNet Selling
CPRX
CATALYST PHARMACEUTICALS INC
AA$2.87B121,975,15279.95%15.82%Net SellingNet Selling
BAND
BANDWIDTH INC
BB$409.54M29,762,91568.16%12.76%Net SellingNet Selling
TZOO
TRAVELZOO
BC$138.69M11,095,0783.12%96.88%Net SellingNet Selling
UHS
UNIVERSAL HEALTH SERVICES INC
BC$11.02B64,440,39483.35%12.00%Net BuyingNet Selling
HRTG
HERITAGE INSURANCE HOLDINGS INC
AA$713.16M30,993,27054.40%20.92%Net SellingNet Selling
CIVB
CIVISTA BANCSHARES INC
BA$342.35M15,519,07254.61%25.13%Net BuyingNet Buying
FORR
FORRESTER RESEARCH INC
BB$191.01M19,063,00049.77%42.18%Net SellingNet Selling
PAHC
PHIBRO ANIMAL HEALTH CORP
AB$969.97M40,533,60844.43%55.57%Net Buying
HALO
HALOZYME THERAPEUTICS INC
AB$6.65B123,221,00077.78%22.22%Net SellingNet Selling
VVX
V2X INC
BC$1.41B31,684,49594.68%5.32%Net SellingNet Selling
ODP
ODP CORP
BB$520.13M30,082,42519.00%81.00%Net SellingNet Selling
PENG
PENGUIN SOLUTIONS INC
AB$1.03B53,677,55766.48%33.52%Net SellingNet Selling
AFYA
AFYA LTD
BB$1.70B93,722,83111.22%0.00%
CRD.A
CRAWFORD & CO
AB$495.53M49,453,67914.05%85.95%Net SellingNet Selling
EXPE
EXPEDIA GROUP INC
BC$21.06B127,120,89662.93%37.07%Net SellingNet Selling
SSNC
SS&C TECHNOLOGIES HOLDINGS INC
BC$19.53B246,662,39867.46%32.54%Net SellingNet Selling
RM
REGIONAL MANAGEMENT CORP
BC$279.27M9,920,62044.54%55.46%Net SellingNet Buying
KBR
KBR INC
BC$6.94B129,736,07344.29%55.71%Net SellingNet Buying
BMRN
BIOMARIN PHARMACEUTICAL INC
AB$10.78B191,775,66594.96%1.74%Net SellingNet Selling
EGHT
8X8 INC
BD$233.99M134,479,29270.57%29.43%Net SellingNet Selling
QFIN
QIFU TECHNOLOGY INC
BC$5.61B268,930,49639.98%0.00%
RIGL
RIGEL PHARMACEUTICALS INC
AA$366.74M17,872,43235.94%64.06%Net Selling
LDOS
LEIDOS HOLDINGS INC
BC$19.20B128,718,87275.70%5.65%Net SellingNet Selling
GLRE
GREENLIGHT CAPITAL RE LTD
BB$502.09M34,555,43138.83%61.17%Net SellingNet Selling
MFIN
MEDALLION FINANCIAL CORP
AB$212.61M23,236,48030.80%17.98%Net SellingNet Buying
EWCZ
EUROPEAN WAX CENTER INC
BC$316.88M55,205,11238.60%61.40%Net SellingNet Selling
TXT
TEXTRON INC
AB$13.97B180,538,79984.74%1.63%Net Selling
FSM
FORTUNA MINING CORP
BD$2.11B306,614,00057.41%0.00%
INCY
INCYTE CORP
AC$13.11B193,569,93476.66%23.34%Net SellingNet Selling
DBX
DROPBOX INC
BB$7.91B281,492,64877.34%6.53%Net SellingNet Selling
CEPU
CENTRAL PUERTO SA
BD$1.87B1,514,022,2560.36%0.00%
PTCT
PTC THERAPEUTICS INC
AC$4.06B79,257,01984.70%15.30%Net SellingNet Selling
EDN
EDENOR
BC$1.32B906,455,1000.38%0.00%
INVA
INNOVIVA INC
BD$1.36B62,775,17357.75%42.25%Net SellingNet Selling
IBEX
IBEX LTD
AB$372.96M13,372,40454.73%45.27%Net SellingNet Selling
MAX
MEDIAALPHA INC
BD$734.74M67,469,67545.34%54.66%Net SellingNet Selling
KINS
KINGSTONE COMPANIES INC
AC$207.85M14,005,79736.32%32.27%Net SellingNet Buying
SCS
STEELCASE INC
AB$1.16B114,640,75973.07%8.76%Net SellingNet Selling
BKTI
BK TECHNOLOGIES CORP
AA$151.54M3,673,5944.84%95.16%Net Buying
UPLD
UPLAND SOFTWARE INC
AB$49.28M28,484,27937.49%62.51%Net SellingNet Selling
EXFY
EXPENSIFY INC
AD$206.06M92,403,05734.40%14.64%Net SellingNet Selling
AKAM
AKAMAI TECHNOLOGIES INC
BC$11.26B146,206,37491.20%8.80%Net SellingNet Selling
GILD
GILEAD SCIENCES INC
BC$136.81B1,243,929,12183.47%1.11%Net SellingNet Selling
XYF
X FINANCIAL
AC$778.21M253,256,3630.36%0.00%
UPWK
UPWORK INC
AB$1.82B131,589,90957.33%42.67%Net SellingNet Selling
CCL
CARNIVAL CORP
BA$30.36B1,354,862,62759.78%34.35%Net SellingNet Selling
DDL
DINGDONG (CAYMAN) LTD
BC$454.63M324,576,75722.16%0.00%
EVER
EVERQUOTE INC
AB$891.62M36,156,54355.60%44.40%Net SellingNet Selling
GRC
GORMAN RUPP CO
AB$933.98M26,294,37759.13%40.87%
ESP
ESPEY MFG & ELECTRONICS CORP
AC$115.75M2,831,39920.06%43.12%Net SellingNet Selling
NVO
NOVO NORDISK A S
BC$356.44B4,465,000,0007.25%0.00%
CPA
COPA HOLDINGS SA
BC$4.27B41,172,95666.38%0.00%

Upgrade to Premium to View More

Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More

Already have a premium account? Sign In

Find the Best Value Stocks to Buy Now 

Value stocks represent the opportunity to buy shares of solid, reliable companies at a great price.

Traditionally, value stocks are associated with large, established companies trading at lower valuations relative to fundamentals. These companies typically have strong financials but may be temporarily undervalued due to things like market sentiment, a reaction to recent earnings, or economic cycles.  

However, you shouldn't just buy stocks because they look "cheap." What appear to be the best value stocks right now based on stock price alone might not have staying power. Locating high-quality value stocks for the long term requires research and due diligence. 

Keep reading to learn:

  • Common characteristics of the top value stocks 
  • How to avoid value investing pitfalls like “value traps”
  • How to locate stocks to buy that align with your investment strategy and goals 

Before we dive in, let’s take a step back and discuss what makes a stock a “value stock” and why some stocks trade at a discount in the first place.

What is a Value Stock? 

A value stock is a stock that appears undervalued based on fundamental metrics such as the price-to-earnings (P/E) ratio, price-to-book (P/B) ratio, or dividend yield.

For example, if a company’s book value is $50 per share, calculated by dividing its market capitalization by outstanding shares, but the stock trades at $45, analysts may see it as a value opportunity.

Value stocks are typically associated with high quality companies with stable earnings growth. Many, but not all, value stocks pay dividends. This is in contrast to growth stocks, which aim for rapid expansion and earnings growth and to outperform the market or their industry or sector. 

Value stocks also typically have lower potential returns but experience less volatility than growth stocks. Value investors buy stocks expecting their price to rise as the market recognizes their true value.

What are Classic Valuation Metrics?

Here are some of the most common metrics used to determine whether a stock is overvalued, fairly valued, or undervalued:

  • Price-to-Earnings (P/E) Ratio: Compares how much you are paying per dollar the company earns. It’s calculated by dividing the stock price by earnings per share (EPS).
  • Price-to-Book (P/B) Ratio: Compares a stock's price to its book value per share, which can be useful for evaluating asset-heavy companies.
  • Price-to-Sales (P/S) Ratio: Compares a company's stock price to its revenue per share, often used for companies with low or no earnings.
  • Dividend Yield: For stocks that pay dividends, this calculates dividend payments as a percentage of the stock price. Dividend yield is particularly relevant for income-focused investors.

However, that leads to an important point — simply relying on traditional value metrics may not be enough to identify the best opportunities. That brings us to important considerations you should know about value stocks…

Important Considerations for Value Stocks 

1. Classic Value Metrics May Not Be Enough 

The stock market has changed in the past few years. Experienced portfolio managers no longer make the majority of decisions or even buy stocks. Algorithmic trading now dominates Wall Street, with most institutional trades executed by quantitative models.

Early on, these models leveraged traditional value metrics such as price-to-earnings (P/E), book value, PEG ratio, and dividend yield if the company pays dividends. However, after years of relentless high-volume trading, the effectiveness of individual value metrics has diminished.

The real edge now comes from combining multiple factors to maximize the probability of success — just like the 21 Value metrics built into our proprietary Zen Ratings model.

Each of these 21 Value metrics has been rigorously tested and shown to identify stocks that consistently outperform the stock market and have ample room to grow. While the advantage of any single metric may be small, stacking 21 independent value criteria together significantly strengthens the odds of long-term outperformance. These include: 

  • Estimated Earnings Yield: Measures projected earnings against the stock’s current price.
  • EBIT/Enterprise Value: Evaluates operating income in relation to the company's overall worth.
  • Cash Flow Yield: Analyzes how a company’s cash flow compares to its market price.
  • Free Cash Flow to Price: Examines how a company’s valuation aligns with its free cash flow generation.
  • P/E Growth (PEG ratio): Adjusts the P/E ratio by factoring in expected growth.

2. Avoid Value Traps 

Many investors get so focused on specific value metrics like a low P/E ratio that they’re blinded to major red flags. 

Stocks with a low P/E ratio can be appealing, but it’s important to consider why it’s so low. Value traps occur when investors fail to recognize that a low P/E may signal a deteriorating earnings outlook. It can be a sign that a company is on a downward trajectory. 

The best way to avoid value traps? Look at more than just value to ensure that you invest in financially strong, growing companies.

Zen Ratings helps you look at value and beyond in stocks by evaluating 26 financial strength factors and 22 growth factors. Companies that earn A or B ratings in these categories provide strong evidence of sound, solid fundamentals throughout.

By taking this comprehensive approach, the odds of selecting companies with improving earnings prospects increase significantly, leading to more earnings beats and higher stock prices.  

3. Lack of Timeliness 

Value investing is considered a contrarian investing style because in essence, you are betting on companies that are currently out of favor on Wall Street.

Unfortunately, that can take time, and it can hinder your return on investment (ROI). 

Happily, Zen Ratings can help you gain a bigger-picture view. In addition to 21 Value Factors, it also zeroes in on 23 different factors that greatly increase the timeliness and ROI of your stocks — namely, 22 Momentum Factors and one AI Factor

Our Momentum models review a combination of short-term, medium-term, and long-term measures of positive price action that increase the odds the stock will stay in favor. Our Artificial Intelligence factor employs sophisticated cross-validation techniques, functioning as an internal system of checks and balances to ensure it isn't just fine-tuned for past performance but remains adaptable to future market conditions.

This approach prevents overfitting, meaning the AI doesn’t just excel in specific historical scenarios — it learns to recognize patterns that apply across various market environments, enhancing its long-term reliability.

The Bottom Line on Value Stocks 

For long-term investors, locating great value stocks requires a big-picture approach — and perhaps counterintuitively, the ability to look beyond just the intrinsic value alone. That’s because valuation is only one aspect of a stock’s bigger picture.

Yes, value investors — or really, anyone who doesn’t want to overpay for stocks — should attempt to select not only stocks that have an overall A or B Zen Rating but those with an A or B Value rating. Our Best Value Stocks to Buy Now Screener can help you quickly sift through the stocks with the highest Value ratings. 

However, our Zen Ratings system allows you to look at more than just value. In addition to seeing how a stock fares for Value, you can also see its prospects for Growth, Financials, Momentum, AI, and more. 

And if you’re struggling to locate Strong Buy value stocks? Our Zen Investor portfolio includes hand-selected stock picks that all have A or B Zen Ratings — A-rated stocks have historically generated an average return of 32.52%, while B-rated stocks have historically generated 19.88% returns. Gain access to the market-beating Zen Investor portfolio now


WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.